This site uses cookies to offer you a better browsing experience. By continuing to access the web site, you agree that we will store personal data in a cookie as outlined in our Privacy Policy, which is also accessible from the sidebar.
Sign up to save, edit, and PDF your reports and access more resources.

Procedure (select all that apply)

Specimen Integrity
Integrity of Right Ovary
Integrity of Left Ovary
Integrity of Right Fallopian Tube
Integrity of Left Fallopian Tube

Tumor Site

Ovarian Surface Involvement (required only if applicable)

Fallopian Tube Surface Involvement (required only if applicable)

Tumor Size (cm)

Histologic Type (select all that apply)

Histologic Grade
Required for serous, endometrioid, mucinous, and seromucinous carcinomas, immature teratomas, and Sertoli-Leydig cell tumors only Note: Serous carcinomas are graded via a 2-tier system. Immature teratomas can be graded using a 2-tier or 3-tier system. Endometrioid and mucinous carcinomas are graded via a 3-tier system. Sertoli-Leydig cell tumors are graded via a modified 3-tier grading system with grade 2 tumors being termed “intermediate differentiated.” Clear cell carcinomas, borderline epithelial neoplasms, all other malignant sex-cord stromal and germ cell tumors are not graded.
WHO Grading System
Two-Tier Grading System (required for immature teratomas and serous carcinomas only)


Other Tissue/ Organ Involvement

Largest Extrapelvic Peritoneal Focus (required only if applicable)

Peritoneal / Ascitic Fluid Involvement

Chemotherapy Response Score (CRS)
Required only for high-grade serous carcinomas. Treatment effect is based on assessment of the section of omentum that shows the least response to chemotherapy.
Regional Lymph Nodes

Distant Site(s) Involved, if applicable

Pathologic Staging (pTNM)
TNM Descriptors (select all that apply)
N suffix modifiers (if applicable)

+ FIGO Stage (2015)